The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis
Open accessAbstract
BACKGROUND AND AIMS Fatty acid translocase CD36 (CD36) is a membrane protein with multiple immuno-metabolic functions. Palmitoylation has been suggested to regulate the distribution and functions of CD36, but little is known about its significance in non-alcoholic steatohepatitis (NASH). METHODS Human liver tissue samples were obtained from patients undergoing liver biopsy for diagnostic purposes. CD36 knockout mice were injected with lentiviral vectors expressing wild-type CD36 or CD36 with mutated palmitoylation sites. Liver histology, immunofluorescence, mRNA expression profile, subcellular distributions and functions of CD36 protein were assessed. RESULTS The localization of CD36 on the plasma membrane of hepatocytes was markedly increased in patients with NASH compared to patients with normal liver and those with simple steatosis. Increased CD36 palmitoylation and increased localization of CD36 on the plasma membrane of hepatocytes were also observed in livers of mice with NASH. Furthermore, inhibition of CD36 palmitoylation protected mice from developing NASH. The absence of palmitoylation decreased CD36 protein hydrophobicity reducing its localization on the plasma membrane as well as in lipid raft of hepatocytes. Consequently, a lack of palmitoylation decreased fatty acid uptake and CD36/Fyn/Lyn complex in HepG2 cells. Inhibition of CD36 palmitoylation not only ameliorated intracellular lipid accumulation via activation of the AMPK pathway, but also inhibited the inflammatory response through the inhibition of the JNK signaling pathway. CONCLUSIONS Our findings demonstrate the key role of palmitoylation in regulating CD36 distributions and its functions in NASH. Inhibition of CD36 palmitoylation may represent an effective therapeutic strategy in patients with NASH. LAY SUMMARY Fatty acid translocase CD36 (CD36) is a multifunctional membrane protein which contributes to the development of liver steatosis. In the present study, we demonstrated that the localization of CD36 on the plasma membrane of hepatocytes is increased in patients with non-alcoholic steatohepatitis. Blocking the palmitoylation of CD36 reduces CD36 distribution in hepatocyte plasma membranes and protects mice from non-alcoholic steatohepatitis. The inhibition of CD36 palmitoylation not only improved fatty acid metabolic disorders but also reduced the inflammatory response in vitro and in vivo. The present study suggests that CD36 palmitoylation is important for non-alcoholic steatohepatitis development and inhibition of CD36 palmitoylation could be used to cure non-alcoholic steatohepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
Flegal, K. M., Carroll, M. D., Kit, B. K., & Ogden, C. L. (2012) · JAMA · doi:10.1001/jama.2012.39 · Cited by 5,385
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 5×
“[11] Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, et al.”
BackgroundMethodInfluentialSheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Lazo, M., Hernaez, R., Eberhardt, M. S., Bonekamp, S., Kamel, I., Guallar, E., Koteish, A., Brancati, F. L., & Clark, J. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws448 · Cited by 797
Coburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
Functional genomic screen reveals genes involved in lipid-droplet formation and utilization
Guo, Y., Walther, T. C., Rao, M., Stuurman, N., Goshima, G., Terayama, K., Wong, J. S., Vale, R. D., Walter, P., & Farese, R. V. (2008) · Nature · doi:10.1038/nature06928 · Cited by 719
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 619
Sayiner, M., Koenig, A., Henry, L., & Younossi, Z. M. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.001 · Cited by 529
Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity
Koonen, D. P. Y., Jacobs, R. L., Febbraio, M., Young, M. E., Soltys, C.-L. M., Ong, H., Vance, D. E., & Dyck, J. R. B. (2007) · Diabetes · doi:10.2337/db07-0907 · Cited by 511
Wilson, C. G., Tran, J. L., Erion, D. M., Vera, N. B., Febbraio, M., & Weiss, E. J. (2016) · Endocrinology · doi:10.1210/en.2015-1866 · Cited by 463
The Palmitoylation Machinery Is a Spatially Organizing System for Peripheral Membrane Proteins
Rocks, O., Gerauer, M., Vartak, N., Koch, S., Huang, Z.-P., Pechlivanis, M., Kuhlmann, J., Brunsveld, L., Chandra, A., Ellinger, B., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.007 · Cited by 454
Miquilena-Colina, M. E., Lima-Cabello, E., Sánchez-Campos, S., García-Mediavilla, M. V., Fernández-Bermejo, M., Lozano-Rodríguez, T., Vargas-Castrillón, J., Buqué, X., Ochoa, B., Aspichueta, P., et al. (2011) · Gut · doi:10.1136/gut.2010.222844 · Cited by 451
Gene expression in human NAFLD
Greco, D., Kotronen, A., Westerbacka, J., Puig, O., Arkkila, P., Kiviluoto, T., Laitinen, S., Kolak, M., Fisher, R. M., Hamsten, A., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00074.2008 · Cited by 427
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384 · cited 2×
“[38] Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, et al.”
BackgroundFunctional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
Tuncman, G., Hirosumi, J., Solinas, G., Chang, L., Karin, M., & Hotamisligil, G. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603509103 · Cited by 350
CD36 in chronic kidney disease: novel insights and therapeutic opportunities
Yang, X., Okamura, D. M., Lu, X., Chen, Y., Moorhead, J., Varghese, Z., & Ruan, X. Z. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.126 · Cited by 264
Self-citationRegulation of AMPK Activation by CD36 Links Fatty Acid Uptake to β-Oxidation
Samovski, D., Sun, J., Pietka, T., Gross, R. W., Eckel, R. H., Su, X., Stahl, P. D., & Abumrad, N. A. (2015) · Diabetes · doi:10.2337/db14-0582 · Cited by 221
FAT/CD36-mediated Long-Chain Fatty Acid Uptake in Adipocytes Requires Plasma Membrane Rafts
Pohl, J., Ring, A., Korkmaz, Ü., Ehehalt, R., & Stremmel, W. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0616 · Cited by 210
Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
Woods, A., Williams, J. R., Muckett, P. J., Mayer, F. V., Liljevald, M., Bohlooly-Y, M., & Carling, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.011 · Cited by 204
Chen, K., Febbraio, M., Li, W., & Silverstein, R. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.172064 · Cited by 202
Kennedy, D. J., Kuchibhotla, S., Westfall, K. M., Silverstein, R. L., Morton, R. E., & Febbraio, M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq360 · Cited by 197
CD36 Is Palmitoylated on Both N- and C-terminal Cytoplasmic Tails
Tao, N., Wagner, S. J., & Lublin, D. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22315 · Cited by 197
Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 195
From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake
Glatz, J. F. C., & Luiken, J. J. F. P. (2017) · Biochimie · doi:10.1016/j.biochi.2016.12.007 · Cited by 194
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults
Marengo, A., Jouness, R. I. K., & Bugianesi, E. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.010 · Cited by 141
Raney, M. A., & Turcotte, L. P. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01282.2007 · Cited by 138
Free Fatty Acid Uptake in Humans With CD36 Deficiency
Hames, K. C., Vella, A., Kemp, B. J., & Jensen, M. D. (2014) · Diabetes · doi:10.2337/db14-0369 · Cited by 132
Zeng, J., Deng, S., Wang, Y., Li, P., Lian, T., & Pang, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.763532 · Cited by 130
Wong, V. W., Wong, G. L., Chim, A. M., Tse, A. M. L., Tsang, S. W., Hui, A., Choi, P. C., Chan, A. W. H., So, W., Chan, F. K. L., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01933.x · Cited by 126
Long-Chain Fatty Acid Uptake into Adipocytes Depends on Lipid Raft Function
Pohl, J., Ring, A., Ehehalt, R., Schulze‐Bergkamen, H., Schad, A., Verkade, P., & Stremmel, W. (2004) · Biochemistry · doi:10.1021/bi035743m · Cited by 115
CD36 actions in the heart: Lipids, calcium, inflammation, repair and more?
Abumrad, N. A., & Goldberg, I. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.015 · Cited by 114
Yamada, E., Pessin, J. E., Kurland, I. J., Schwartz, G. J., & Bastie, C. C. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.12.010 · Cited by 98
The Integrins α3β1 and α6β1 Physically and Functionally Associate with CD36 in Human Melanoma Cells
Thorne, R. F., Marshall, J. F., Shafren, D. R., Gibson, P. G., Hart, I. R., & Burns, G. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003969200 · Cited by 89
Thorne, R. F., Ralston, K. J., de Bock, C. E., Mhaidat, N. M., Zhang, X. D., Boyd, A., & Burns, G. F. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.07.002 · Cited by 84
Nonalcoholic fatty liver disease in A sia: A story of growth
Wong, V. W. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12011 · Cited by 77
Increased soluble CD 36 is linked to advanced steatosis in nonalcoholic fatty liver disease
García‐Monzón, C., Iacono, O. L., Crespo, J., Romero‐Gómez, M., García‐Samaniego, J., Fernández‐Bermejo, M., Domínguez‐Díez, A., de Cía, J. R., Sáez, A., Carro, J. L. P., et al. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12192 · Cited by 59
Zhao, L., Zhong, S., Qu, H., Xie, Y., Cao, Z., Li, Q., Yang, P., Varghese, Z., Moorhead, J. F., Chen, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep10222 · Cited by 58
Self-citationTargeting protein palmitoylation: selective inhibitors and implications in disease
Chavda, B., Arnott, J. A., & Planey, S. L. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.933802 · Cited by 57
Wallin, T., Ma, Z., Ogata, H., Jørgensen, I. H., Iezzi, M., Wang, H., Wollheim, C. B., & Björklund, A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.002 · Cited by 48
Jochen, A., & Hays, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35741-2 · Cited by 48
Eyre, N. S., Cleland, L. G., Tandon, N. N., & Mayrhofer, G. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600255-jlr200 · Cited by 44
Yoshimura, K., Okanoue, T., Ebise, H., Iwasaki, T., Mizuno, M., Shima, T., Ichihara, J., & Yamazaki, K. (2015) · Hepatology · doi:10.1002/hep.28226 · Cited by 38
van Oort, M. M., Drost, R., Janβen, L., DOORN, J. M. V., Kerver, J., HORST, D. J. V. D., Luiken, J. J. F. P., & Rodenburg, K. W. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.876049 · Cited by 26
Cited by
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada, P., González-Rodríguez, Á., García-Monzón, C., & Valverde, Á. M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03003-w · Cited by 518
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
NAFLD: Mechanisms, Treatments, and Biomarkers
Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 405
CD36 tango in cancer: signaling pathways and functions
Wang, J., & Li, Y. (2019) · Theranostics · doi:10.7150/thno.36037 · Cited by 368
Metadata
- Authors
- Zhao, L., Zhang, C., Luo, X., Wang, P., Zhou, W., Zhong, S., Xie, Y., Jiang, Y., Yang, P., Tang, R., Pan, Q., Hall, A. R., Luong, T. V., Fan, J., Varghese, Z., Moorhead, J. F., Pinzani, M., Chen, Y., & Ruan, X. Z.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 69
- Issue
- 3
- Pages
- 705-717
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2800979787
- Cited by
- 313
- References
- 43
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.